The clinical trial of blood kinetics upon the ingestion of fat-soluble foods. -A Randomized Double-blind Placebo-controlled Crossover trial- - The clinical trial of blood kinetics upon the ingestion of fat-soluble foods. -A Randomized Double-blind Placebo-controlled Crossover trial

Medical Corporation Hokubukai Utsukushigaoka Hospital0 sites30 target enrollmentDecember 31, 2020

Overview

No summary available.

Registry

who.int

Start Date

December 31, 2020

End Date

April 30, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Medical Corporation Hokubukai Utsukushigaoka Hospital

•(1\) Subjects with hepatic, renal, cardiac or organ disorders or diabetes or other serious diseases. (2\) Subjects with a surgical history of the digestive system (except appendicectomy). (3\) Subjects with a history of a drug or food allergy. (4\) Subjects currently under treatment with chronic diseases. (5\) Subjects who are pregnant or intend to become pregnant during the study or are lactating. (6\) Subjects who cannot restrict the intake of foods that may influence the measurement of the samples during the study. (7\) Subjects who take excessive alcohol (equivalent to 60 g pure ethanol/day in average consumption). (8\) Subjects who participate in other clinical trials. (9\) Subjects who have a history of feeling ill or unwell during or after the blood draw. (10\) Subjects who have donated over 400 mL of blood within the last three months prior to the screening of this study or expect to donate the same during the study. (11\) Subjects with extremely irregular diet (night\-shift worker, etc). (12\) Subjects who have smoked within 6 months. (13\) Subjects who need to avoid taking the foods that do not clearly indicate the origin of all ingredients, because of religions, etc. (14\) Subjects judged as unsuitable for this study by the investigator for other reasons.